Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06667401 · ClinicalTrials.gov registry record

Exploring the Efficacy of Assistive Artificial Intelligence for Ultrasound Guided Regional Anesthesia in Residency Training

A clinical trial, sponsored by Medical College of Wisconsin.

Completed
Registry status
20
Enrollment target

NCT06667401: Completed study, sponsored by Medical College of Wisconsin.

NCT06667401 is a clinical trial that has completed, run by Medical College of Wisconsin. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06667401 has completed, sponsored by Medical College of Wisconsin.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the efficacy of a novel artificial intelligence (AI) device designed to assist in Ultrasound guided regional anesthesia (ScanNav Anatomy Peripheral Nerve Block; ScanNav), in the teaching and training of anesthesiology residents in the subspecialty of regional anesthesia.

Primary Outcome

Improved teaching and training of anesthesiology residents in the subspecialty of regional anesthesia will be accessed via a questionnaire filled out by participants after use of the device. The questionnaire will access, the type of regional blocks, feasibility of block and ease of teaching with the artificial intelligence Ultrasound.

Interventions

  • DEVICE The ScanNav, a novel artificial intelligence device designed to assist in Ultrasound guided regional anesthesia

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2025-03-10
Est. Completion 2026-01-01
Medical College of Wisconsin

447 total trials

What the finished NCT06667401 record still lists

NCT06667401 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which The ScanNav, a novel artificial intelligence device designed to assist in Ultrasound guided regional anesthesia is the first listed.

NCT06667401 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06667401 about?

NCT06667401 is a clinical study titled "Exploring the Efficacy of Assistive Artificial Intelligence for Ultrasound Guided Regional Anesthesia in Residency Training". The purpose of this study is to investigate the efficacy of a novel artificial intelligence (AI) device designed to assist in Ultrasound guided regional anesthesia (ScanNav Anatomy Peripheral Nerve Block; ScanNav), in the teaching and training of anesthesiology residents in the subspecialty of regio...

What is the current status of trial NCT06667401?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2025-03-10. Estimated completion is 2026-01-01.

What interventions are being tested in trial NCT06667401?

The interventions under investigation include: The ScanNav, a novel artificial intelligence device designed to assist in Ultrasound guided regional anesthesia (DEVICE).

Who is sponsoring clinical trial NCT06667401?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06667401, the US trial registry maintained by the National Library of Medicine. NCT06667401 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.